Project to Update the Study of Congenital Haemophilia in Spain
NCT01959555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1157
Last updated 2015-11-30
Summary
This study is conducted in Europe. The aim of the study is to update the knowledge about the prevalence and severity of congenital haemophilia (A and B) in Spain.
Conditions
- Congenital Bleeding Disorder
- Haemophilia A
- Haemophilia B
Interventions
- OTHER
-
No treatment given
Patients will not be treated with any specific product. Data collection only.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities
NCT04584892 ·Status: COMPLETED
-
Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia
NCT07099313 ·Status: RECRUITING
-
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
NCT06940830 ·Status: RECRUITING ·Phase: PHASE4
-
Transcultural Multidisciplinary Evaluation of Patients With Hemophili
NCT02199639 ·Status: UNKNOWN
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
Adherence to Treatment in Hemophilia
NCT02191436 ·Status: UNKNOWN
-
Study Evaluating Liver Transplantation in Haemophilia Patients in Spain
NCT00927992 ·Status: COMPLETED
-
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Bleeding Symptoms of Carriers of Hemophilia A and B
NCT01029808 ·Status: COMPLETED
-
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
NCT03276130 ·Status: COMPLETED
-
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries
NCT01503567 ·Status: COMPLETED
-
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
NCT01988532 ·Status: COMPLETED
-
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
NCT03741881 ·Status: COMPLETED
-
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
NCT02225483 ·Status: COMPLETED
-
Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
NCT01493778 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Quarantine on Musculoskeletal Status in Hemophilia
NCT04491318 ·Status: COMPLETED
-
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
NCT03528551 ·Status: COMPLETED ·Phase: PHASE3
-
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice
NCT01579955 ·Status: COMPLETED
-
Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World
NCT01217255 ·Status: COMPLETED
-
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
NCT01480180 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A
NCT02941354 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors
NCT01505946 ·Status: UNKNOWN
-
Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
NCT02256917 ·Status: COMPLETED ·Phase: PHASE3